Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.47% | 131.02 | 0.0% | $2314.17m | |
| BNGO | BioNano Genomics, Inc. | 18.50% | 9.80 | 0.0% | $2016.46m | |
| GILD | Gilead Sciences, Inc. | -0.06% | 66.94 | 1.0% | $649.72m | |
| AMGN | Amgen, Inc. | 0.58% | 253.50 | 1.3% | $564.60m | |
| CRSP | CRISPR Therapeutics AG | 1.83% | 188.49 | 0.6% | $487.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.43% | 537.78 | 2.7% | $478.09m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.19% | 159.73 | 2.0% | $470.59m | |
| NVAX | Novavax, Inc. | 3.74% | 126.98 | 92.9% | $417.43m | |
| ILMN | Illumina, Inc. | 0.34% | 406.25 | 3.5% | $396.72m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.36% | 98.24 | 13.8% | $364.79m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.44% | 237.59 | 1.9% | $361.85m | |
| BIIB | Biogen, Inc. | -0.25% | 269.44 | 1.7% | $321.90m | |
| BNTX | BioNTech SE | 2.86% | 108.44 | 0.0% | $298.33m | |
| EXAS | EXACT Sciences Corp. | 1.30% | 150.00 | 19.6% | $243.95m | |
| PACB | Pacific Biosciences of California, Inc. | 3.06% | 37.42 | 7.4% | $228.17m |
Company Profile
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.